Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patientsSAMPOGNA, F; BOUWES BAVINCK, J. N; NINDL, I et al.Journal of general virology. 2012, Vol 93, pp 165-174, issn 0022-1317, 10 p., 1Article

Marked differences in Betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitisDE KONING, M. N. C; POLDERMAN, M. C. A; WATERBOER, T et al.British journal of dermatology (1951). 2011, Vol 164, Num 4, pp 771-775, issn 0007-0963, 5 p.Article

Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006WISGERHOF, H. C; EDELBROEK, J. R. J; DE FIJTER, J. W et al.British journal of dermatology (1951). 2010, Vol 162, Num 2, pp 390-396, issn 0007-0963, 7 p.Article

A Case-Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant RecipientsPROBY, C. M; HARWOOD, C. A; WATERBOER, T et al.American journal of transplantation (Print). 2011, Vol 11, Num 7, pp 1498-1508, issn 1600-6135, 11 p.Article

In vitro detection of fluorescent tumor-specific cytotoxic T cell clonesTOES, R. E. M; DEN HAAN, J. M. M; FELTKAMP, M. C. W et al.Journal of immunological methods. 1993, Vol 163, Num 1, pp 23-32, issn 0022-1759Article

Transcriptional activation of the major immediate early transcription unit of human cytomegalovirus by heat-shock, arsenite and protein synthesis inhibitorsGEELEN, J. L. M. C; BOOM, R; KLAVER, G. P. M et al.Journal of general virology. 1987, Vol 68, Num 2, pp 2925-2931, issn 0022-1317Article

Fatal Scedosporium prolificans infection in a leukemic patientFELTKAMP, M. C. W; KERSTEN, M. J; VAN DER LELIE, J et al.European journal of clinical microbiology & infectious diseases (Print). 1997, Vol 16, Num 6, pp 460-464, issn 0934-9723Article

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumorOSSEVOORT, M. A; FELTKAMP, M. C. W; VAN VEEN, K. J. H et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 18, Num 2, pp 86-94, issn 1067-5582Conference Paper

Tumor rejection antigens and tumor specific cytotoxic T lymphocytesTOES, R. E. M; OFFRINGA, R; FELTKAMP, M. C. W et al.Behring-Institute-Mitteilungen. 1994, Num 94, pp 72-86, issn 0301-0457Article

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cellsFELTKAMP, M. C. W; SMITS, H. L; VIERBOOM, M. P. M et al.European journal of immunology. 1993, Vol 23, Num 9, pp 2242-2249, issn 0014-2980Article